Difficulty: Medium
Average Score: 66%
Practice
Which of the following neuromuscular blocking drugs is an intermediate-duration muscle relaxant?
Correct answer
A
Rationale
In the context of cardiovascular drugs pharmacology, understanding neuromuscular blocking agents is crucial for nursing practice, especially in settings where patients require muscle relaxation for intubation or surgery.
The correct answer is A) Vecuronium, an intermediate-duration muscle relaxant. Vecuronium is a non-depolarizing neuromuscular blocking agent that acts by competitively binding to nicotinic cholinergic receptors at the motor endplate, leading to muscle paralysis. Its intermediate duration of action makes it suitable for maintaining muscle relaxation during surgical procedures.
Option B) Tubocurarine is a non-depolarizing neuromuscular blocking agent with a longer duration of action compared to Vecuronium. It is considered a long-acting muscle relaxant and is associated with more side effects.
Option C) Pancuronium is a non-depolarizing neuromuscular blocking agent with a longer duration of action similar to Tubocurarine. It is not classified as an intermediate-duration muscle relaxant.
Option D) Rapacuronium is a non-depolarizing neuromuscular blocking agent that was withdrawn from the market due to the potential risk of severe bronchospasm.
Understanding the duration of action and characteristics of neuromuscular blocking agents is essential for safe and effective administration in clinical practice. Nurses need to be familiar with the different types of muscle relaxants to ensure optimal patient care and outcomes during procedures requiring muscle relaxation.
The correct answer is A) Vecuronium, an intermediate-duration muscle relaxant. Vecuronium is a non-depolarizing neuromuscular blocking agent that acts by competitively binding to nicotinic cholinergic receptors at the motor endplate, leading to muscle paralysis. Its intermediate duration of action makes it suitable for maintaining muscle relaxation during surgical procedures.
Option B) Tubocurarine is a non-depolarizing neuromuscular blocking agent with a longer duration of action compared to Vecuronium. It is considered a long-acting muscle relaxant and is associated with more side effects.
Option C) Pancuronium is a non-depolarizing neuromuscular blocking agent with a longer duration of action similar to Tubocurarine. It is not classified as an intermediate-duration muscle relaxant.
Option D) Rapacuronium is a non-depolarizing neuromuscular blocking agent that was withdrawn from the market due to the potential risk of severe bronchospasm.
Understanding the duration of action and characteristics of neuromuscular blocking agents is essential for safe and effective administration in clinical practice. Nurses need to be familiar with the different types of muscle relaxants to ensure optimal patient care and outcomes during procedures requiring muscle relaxation.